The High Prevalence of Short-Term Elevation of Tumor Markers Due to Hyperglycemia in Diabetic Patients

References

• Saeedi P, Petersohn I, Salpea P, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the international diabetes federation diabetes atlas, 9th edition. Diabetes Res Clin Pract. 2019;157:107843. doi:10.1016/j.diabres.2019.107843
   PubMed Web of Science ®Google Scholar
• Ma RCW. Epidemiology of diabetes and diabetic complications in China. Diabetologia. 2018;61(6):1249–1260. doi:10.1007/s00125-018-4557-7
   PubMed Web of Science ®Google Scholar
• Abudawood M. Diabetes and cancer: a comprehensive review. J Res Med Sci. 2019;24:94. doi:10.4103/jrms.JRMS_242_19
   PubMed Web of Science ®Google Scholar
• Srivastava SP, Goodwin JE. cancer biology and prevention in diabetes. Cells. 2020;9(6):1380. doi:10.3390/cells9061380
   PubMed Web of Science ®Google Scholar
• Tsilidis KK, Kasimis JC, Lopez DS, et al. Type 2 diabetes and cancer: umbrella review of meta-analyses of observational studies. BMJ. 2015;350:g7607. doi:10.1136/bmj.g7607
   PubMed Web of Science ®Google Scholar
• Cheng Y-C, Yu-Hsuan L, Hsu C-Y, et al. Synergistic association of carcinoembryonic antigen and carbohydrate antigen 19-9 on the risk of abnormal glucose regulation diabetes. Metab Syndr Obes. 2020;13:1933–1942. doi:10.2147/DMSO.S256223
   PubMed Web of Science ®Google Scholar
• Chung S, Lee Y, Roh EY. HbA1c showed a positive association with carcinoembryonic antigen (CEA) level in only diabetes, not prediabetic or normal individuals. J Clin Lab Anal. 2019;33(6):e22900. doi:10.1002/jcla.22900
   PubMed Web of Science ®Google Scholar
• Chen J, Tao F, Zhang B, et al. Elevated squamous cell carcinoma antigen, cytokeratin 19 fragment, and carcinoembryonic antigen levels in diabetic nephropathy. Int J Endocrinol. 2017;2017:5304391. doi:10.1155/2017/5304391
   Web of Science ®Google Scholar
• Jeong S, Park MJ, Song W, et al. Current immunoassay methods and their applications to clinically used biomarkers of breast cancer. Clin Biochem. 2020;78:43–57. doi:10.1016/j.clinbiochem.2020.01.009
   Web of Science ®Google Scholar
• Bergman M, Abdul-Ghani M, DeFronzo RA, et al. Review of methods for detecting glycemic disorders. Diabetes Res Clin Pract. 2020;165:108233. doi:10.1016/j.diabres.2020.108233
   PubMed Web of Science ®Google Scholar
• Burchill MA, Finlon JM, Goldberg AR, et al. Oxidized low-density lipoprotein drives dysfunction of the liver lymphatic system. Cell Mol Gastroenterol Hepatol. 2021;11(2):573–595. doi:10.1016/j.jcmgh.2020.09.007
   Web of Science ®Google Scholar
• Dai B, Xu L, Jiankun X, et al. Synergistic effects of magnesium ions and simvastatin on attenuation of high-fat diet-induced bone loss. Bioact Mater. 2021;6(8):2511–2522. doi:10.1016/j.bioactmat.2021.01.027
   Web of Science ®Google Scholar
• Wojciechowska J, Krajewski W, Bolanowski M, et al. Diabetes and cancer: a review of current knowledge. Exp Clin Endocrinol Diabetes. 2016;124(5):263–275. doi:10.1055/s-0042-100910
   PubMed Web of Science ®Google Scholar
• Harding JL, Andes LJ, Gregg EW, et al. Trends in cancer mortality among people with vs. without diabetes in the USA, 1988–2015. Diabetologia. 2020;63:75–84. doi:10.1007/s00125-019-04991-x
   Web of Science ®Google Scholar
• Suh S, Kim KW. Diabetes and cancer: cancer should be screened in routine diabetes assessment. Diabetes Metab J. 2019;43(6):733–743. doi:10.4093/dmj.2019.0177
   PubMed Web of Science ®Google Scholar
• Martins ÁM, Ramos CC, Freitas D, et al. Glycosylation of cancer extracellular vesicles: capture strategies, functional roles and potential clinical applications. Cells. 2021;10(1):109. doi:10.3390/cells10010109
   Web of Science ®Google Scholar
• Silsirivanit A. Glycosylation markers in cancer. Adv Clin Chem. 2019;89:189–213.
   PubMed Web of Science ®Google Scholar
• Benchimol S, Fuks A, Jothy S, et al. Carcinoembryonic antigen, a human tumor marker, functions as an intercellular adhesion molecule. Cell. 1989;57(2):327–334. doi:10.1016/0092-8674(89)90970-7
   PubMed Web of Science ®Google Scholar
• Konishi T, Shimada Y, Hsu M, et al. Association of preoperative and postoperative serum carcinoembryonic antigen and colon cancer outcome. JAMA Oncol. 2018;4(3):309–315. doi:10.1001/jamaoncol.2017.4420
   PubMed Web of Science ®Google Scholar
• Lee JY, Lee HK, Lee DC, et al. Serum carcinoembryonic antigen is associated with abdominal visceral fat accumulation in female Korean nonsmokers. PLoS One. 2012;7(8):e43518. doi:10.1371/journal.pone.0043518
   Web of Science ®Google Scholar
• Bae U, Shim JY, Lee HR, et al. Serum carcinoembryonic antigen level is associated with arterial stiffness in healthy Korean adult. Clin Chim Acta. 2013;415:286–289. doi:10.1016/j.cca.2012.10.052
   PubMed Web of Science ®Google Scholar
• Kelleher M, Singh R, O’Driscoll CM, et al. Carcinoembryonic antigen (CEACAM) family members and inflammatory bowel disease. Cytokine Growth Factor Rev. 2019;47:21–31. doi:10.1016/j.cytogfr.2019.05.008
   PubMed Web of Science ®Google Scholar
• Chen PC, Lin HD. Reversible high blood CEA and CA19-9 concentrations in a diabetic patient. Libyan J Med. 2012;7:19572.
   Web of Science ®Google Scholar
• Williams JA, Goldfine ID. The insulin-pancreatic acinar axis. Diabetes. 1985;34(10):980–986. doi:10.2337/diab.34.10.980
   PubMed Web of Science ®Google Scholar
• Yu H, Li R, Zhang L, et al. CA19-9 level associated with metabolic control and pancreatic beta cell function in diabetic patients. Exp Diabetes Res. 2012;2012:745189. doi:10.1155/2012/745189
   Google Scholar
• Weir GC. Glucolipotoxicity, β-Cells, and diabetes: the emperor has no clothes. Diabetes. 2020;69(3):273–278. doi:10.2337/db19-0138
   Web of Science ®Google Scholar
• Lytrivi M, Castell A-L, Poitout V, et al. Recent insights into mechanisms of β-Cell Lipo- and glucolipotoxicity in type 2 diabetes. J Mol Biol. 2020;432(5):1514–1534.22. doi:10.1016/j.jmb.2019.09.016
   PubMed Web of Science ®Google Scholar
• Shang X, Song C, Xiaoming D, et al. The serum levels of tumor marker CA19-9, CEA, CA72-4, and NSE in type 2 diabetes without malignancy and the relations to the metabolic control. Saudi Med J. 2017;38(2):204–208.
   PubMed Web of Science ®Google Scholar
• Li J, Zhang H, Xie M, et al. NSE, a potential biomarker, is closely connected to diabetic peripheral neuropathy. Diabetes Care. 2013;36(11):3405–3410. doi:10.2337/dc13-0590
   PubMed Web of Science ®Google Scholar
• Kubo N, Gang Y, Okuno M, et al. Clinical evaluation of a lung cancer-associated protein antigen, cytokeratin 19 fragment: II. Radioimmunoassay and effect of aging and smoking over serum level of normal individuals. Rinsho Byori. 1993;41(11):1260–1264.
   Google Scholar
• LeRoith D, Biessels GJ, Braithwaite SS, et al. Treatment of Diabetes in Older Adults: an Endocrine Society* Clinical Practice Guideline. J Clin Endocrinol Metab. 2019;104(5):1520–1574.
   PubMed Web of Science ®Google Scholar